---
figid: PMC3883924__nihms501722f2
figtitle: Pathogenesis of alcoholic hepatitis with identification of newer therapeutic
  targets
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Bikinia letestui
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae S288C
- Caenorhabditis elegans
pmcid: PMC3883924
filename: nihms501722f2.jpg
figlink: /pmc/articles/PMC3883924/figure/F2/
number: F2
caption: 'Pathogenesis of alcoholic hepatitis with identification of newer therapeutic
  targets. 1: Alcohol increases gut permeability and allows translocation of bacterial
  lipopolysaccharide which stimulates TLR-4 receptors in liver. Antibiotics, probiotics,
  and immunoglobulin to LPS may attenuate this response. 2: Kupffer cells stimulate
  inflammatory cascades including production of IL-1 which recruits white blood cells.
  Anikinra is an antagonist of IL-1 receptor. Macrophage inflammatory factor is another
  target. 3: TNF-α mediates cell death via caspase-8 (apoptosis) and caspase-1 (sterile
  necrosis). Caspase inhibitor Emricasan is a potential agent blocking final common
  pathway without affecting hepatic regeneration as seen with anti-TNF agents, corticosteroids,
  and other cytokine modulation. FXR agonists may also have hepatoprotective effects
  through multiple mechanisms. (Figure courtesy of Dr. Vikas Verma).'
papertitle: 'Alcoholic Hepatitis: Current challenges and future directions.'
reftext: Ashwani K Singal, et al. Clin Gastroenterol Hepatol. ;12(4):555-564.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6853987
figid_alias: PMC3883924__F2
figtype: Figure
redirect_from: /figures/PMC3883924__F2
ndex: e0966b9a-df30-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3883924__nihms501722f2.html
  '@type': Dataset
  description: 'Pathogenesis of alcoholic hepatitis with identification of newer therapeutic
    targets. 1: Alcohol increases gut permeability and allows translocation of bacterial
    lipopolysaccharide which stimulates TLR-4 receptors in liver. Antibiotics, probiotics,
    and immunoglobulin to LPS may attenuate this response. 2: Kupffer cells stimulate
    inflammatory cascades including production of IL-1 which recruits white blood
    cells. Anikinra is an antagonist of IL-1 receptor. Macrophage inflammatory factor
    is another target. 3: TNF-α mediates cell death via caspase-8 (apoptosis) and
    caspase-1 (sterile necrosis). Caspase inhibitor Emricasan is a potential agent
    blocking final common pathway without affecting hepatic regeneration as seen with
    anti-TNF agents, corticosteroids, and other cytokine modulation. FXR agonists
    may also have hepatoprotective effects through multiple mechanisms. (Figure courtesy
    of Dr. Vikas Verma).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - TNF
  - PYCR1
  - LMNA
  - ZMPSTE24
  - IL1R1
  - PABPN1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - IL15
  - Il1b
  - Tnf
  - Prodh
  - Il1
  - Gusb
  - Il15
  - PRO3
  - PRO1
  - PRO2
  - pro-3
  - pro-1
  - pro-2
---
